Related Experiment Video
Updated: Feb 28, 2026

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
Time-restricted feeding improves cognitive function in Alzheimer's mice through GCK/NPY/apoptosis pathway
Zhijun Zhang1, Jingyun Yang1, Zhili Niu2
1Department of Endocrinology & Metabolism, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Time-restricted feeding (TRF) improves cognitive function and reduces neuronal apoptosis in Alzheimer's disease (AD) models by modulating the GCK/NPY pathway. This dietary intervention shows promise as a non-pharmacological treatment for AD.
Area of Science:
- Neuroscience
- Metabolic Disorders
- Chronobiology
Background:
- Alzheimer's disease (AD) involves cognitive decline, neuronal loss, and disrupted circadian rhythms.
- Time-restricted feeding (TRF) aligns eating with circadian rhythms, showing potential for neurodegenerative disorders.
Purpose of the Study:
- To investigate the effects of TRF on cognitive function and neuronal apoptosis in AD mouse models.
- To elucidate the role of the GCK/NPY/apoptosis pathway in TRF's therapeutic mechanisms for AD.
Main Methods:
- APP/PS1/Tau transgenic mice and wild-type mice were subjected to ad libitum (AL) or TRF for 3 months.
- Cognitive performance was assessed using behavioral tests; hippocampal tissues were analyzed via Western blot, qPCR, and Nissl staining.
- In vitro studies used HT22 cells treated with Aβ and siGCK to examine the GCK/NPY/apoptosis pathway.
Main Results:
- TRF reduced food intake, weight gain, p-Tau accumulation, and hippocampal neuronal apoptosis in AD mice.
- TRF improved cognitive function and restored the GCK/NPY pathway.
- Silencing GCK in vitro reduced p-Tau and apoptosis, while increasing NPY, with recurrence upon GCK re-silencing.
Conclusions:
- TRF enhances cognitive function and mitigates neuronal apoptosis in AD mouse models.
- Modulation of the GCK/NPY pathway is a key mechanism underlying TRF's benefits in AD.
- TRF represents a potential non-pharmacological intervention for Alzheimer's disease.
More Related Videos
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
05:54Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials
Published on: May 10, 2024